인공 혈관 시장 규모, 점유율 및 성장 분석 : 제품 유형별, 소재 유형별, 용도별, 최종사용자별, 시술 유형별, 내경 유형별, 지역별 - 업계 예측(2026-2033년)

Global Artificial Blood Vessels Market size was valued at USD 2.75 Billion in 2024 and is poised to grow from USD 2.91 Billion in 2025 to USD 4.57 Billion by 2033, growing at a CAGR of 5.8% during the forecast period (2026-2033).

The global market for artificial blood vessels is propelled by the high prevalence of cardiovascular diseases, an increase in vascular surgeries, and a rising demand for tissue-engineered grafts. Innovations in tissue engineering, biodegradable materials, and personalized vascular grafts are contributing to improved clinical outcomes and expanding treatment options. Significant investments in regenerative medicine, 3D bioprinting, and stem cell-based applications are further enhancing market growth. The shift towards individualized therapies and the emergence of next-generation artificial grafts are intensifying competition in the sector. Meanwhile, supportive reimbursement policies and enhanced healthcare infrastructure are favorable for the industry. However, challenges such as high costs, stringent regulations, limited long-term evidence, and graft-related complications may impede market penetration and growth prospects.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Artificial Blood Vessels market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Artificial Blood Vessels Market Segments Analysis

Global artificial blood vessels market is segmented by product type, material type, application, end user, procedure type, diameter type, and region. Based on product type, the market is segmented into synthetic vascular grafts, biological vascular grafts, tissue-engineered blood vessels, endovascular grafts, small-diameter vascular grafts, and large-diameter vascular grafts. Based on material type, the market is segmented into Expanded Polytetrafluoroethylene (ePTFE), Polyester (Dacron), polyurethane, biological materials, and hybrid biomaterials. Based on application, the market is segmented into aortic repair, peripheral vascular disease, hemodialysis access, coronary artery bypass, vascular trauma repair, and congenital vascular defects. Based on end user, the market is segmented into hospitals, cardiac surgery centers, vascular surgery centers and ambulatory surgical centers. Based on procedure type, the market is segmented into open surgical repair, endovascular repair, and hybrid procedures. Based on diameter type, the market is segmented into small-diameter grafts, medium-diameter grafts, and large-diameter grafts. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.

Driver of the Global Artificial Blood Vessels Market

A key market driver for the global artificial blood vessels market is the rising incidence of cardiovascular diseases and the growing prevalence of related conditions requiring vascular interventions. As the global population ages and lifestyle-related factors contribute to an increase in heart and vascular disorders, the demand for innovative surgical solutions escalates. Artificial blood vessels offer significant advantages, such as reducing the risk of complications associated with traditional grafts and improving patient outcomes. Additionally, advancements in biomaterials and tissue engineering technologies are fueling product development, enhancing the performance of artificial blood vessels, and thus propelling their adoption in clinical settings.

Restraints in the Global Artificial Blood Vessels Market

One key market restraint for the global artificial blood vessels market is the high cost of production and associated healthcare expenses. The manufacturing processes for artificial blood vessels often involve advanced technologies and materials that require significant investment. This results in higher prices for end-users, potentially limiting accessibility for patients and healthcare providers, especially in developing regions. Furthermore, stringent regulatory approvals and the need for extensive clinical validation can lead to prolonged development timelines, impeding market entry for new products. These factors combined create a challenging environment for broader adoption and commercialization in the healthcare sector.

Market Trends of the Global Artificial Blood Vessels Market

The Global Artificial Blood Vessels market is experiencing a significant trend towards personalized scaffold design, propelled by advancements in patient-specific imaging and three-dimensional printing technologies. Manufacturers are increasingly focusing on creating vascular scaffolds tailored to individual anatomical features, enhancing integration with host tissue and minimizing post-surgical complications. This trend is driving investments in digital design systems and bioink development, fostering collaborations between medtech and biotechnology firms. As companies pivot towards precision medicine, innovative solutions are reshaping supply chains and generating new revenue streams, marking a transformative shift in how artificial blood vessels are produced and utilized in clinical settings.

Table of Contents

Introduction

• Objectives of the Study
• Market Definition & Scope

Research Methodology

• Research Process
• Secondary & Primary Data Methods
• Market Size Estimation Methods

Executive Summary

• Global Market Outlook
• Key Market Highlights
• Segmental Overview
• Competition Overview

Market Dynamics & Outlook

• Macro-Economic Indicators
• Drivers & Opportunities
• Restraints & Challenges
• Supply Side Trends
• Demand Side Trends
• Porters Analysis & Impact
  • Competitive Rivalry
  • Threat of Substitute
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factors
• Market Impacting Factors
• Top Investment Pockets
• Ecosystem Mapping
• Market Attractiveness Index 2025
• PESTEL Analysis
• Regulatory Landscape

Global Artificial blood vessels market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Synthetic Vascular Grafts
• Biological Vascular Grafts
• Tissue-Engineered Blood Vessels
• Endovascular Grafts
• Small-Diameter Vascular Grafts
• Large-Diameter Vascular Grafts

Global Artificial blood vessels market Size by Material Type & CAGR (2026-2033)

• Market Overview
• Expanded Polytetrafluoroethylene (ePTFE)
• Polyester (Dacron)
• Polyurethane
• Biological Materials
• Hybrid Biomaterials

Global Artificial blood vessels market Size by Application & CAGR (2026-2033)

• Market Overview
• Aortic Repair
• Peripheral Vascular Disease
• Hemodialysis Access
• Coronary Artery Bypass
• Vascular Trauma Repair
• Congenital Vascular Defects

Global Artificial blood vessels market Size by End User & CAGR (2026-2033)

• Market Overview
• Hospitals
• Cardiac Surgery Centers
• Vascular Surgery Centers
• Ambulatory Surgical Centers

Global Artificial blood vessels market Size by Procedure Type & CAGR (2026-2033)

• Market Overview
• Open Surgical Repair
• Endovascular Repair
• Hybrid Procedures

Global Artificial blood vessels market Size by Diameter Type & CAGR (2026-2033)

• Market Overview
• Small-Diameter Grafts
• Medium-Diameter Grafts
• Large-Diameter Grafts

Global Artificial blood vessels market Size & CAGR (2026-2033)

• North America (Product Type, Material Type, Application, End User, Procedure Type, Diameter Type)
  • US
  • Canada
• Europe (Product Type, Material Type, Application, End User, Procedure Type, Diameter Type)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Material Type, Application, End User, Procedure Type, Diameter Type)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Material Type, Application, End User, Procedure Type, Diameter Type)
  • Mexico
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Material Type, Application, End User, Procedure Type, Diameter Type)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• W. L. Gore & Associates
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Getinge
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• LeMaitre Vascular
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton Dickinson (BD)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Artivion
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Meril Life Sciences
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• JOTEC
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Braile Biomedica
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascutek
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xeltis
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Humacyte
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Shanghai MicroPort Endovascular
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lifetech Scientific
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cook Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Endologix
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lombard Medical
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Vascular Graft Solutions
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Japan Lifeline
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations